Impact of telomere length on survival in classic and variant hairy cell leukemia

被引:8
|
作者
Arons, Evgeny [1 ]
Zhou, Hong [1 ]
Edelman, Daniel C. [2 ]
Gomez, Allison [2 ]
Steinberg, Seth M. [3 ]
Petersen, David [2 ]
Wang, Yonghong [2 ]
Meltzer, Paul S. [2 ]
Kreitman, Robert J. [1 ]
机构
[1] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA
[2] NCI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA
[3] NCI, Biostat & Data Management Sect, Off Clin Director, Ctr Canc Res,NIH, Bethesda, MD 20892 USA
关键词
Telomere; Hairy cell leukemia; Molecular marker; Chromosomes; DNA damage; CHRONIC LYMPHOCYTIC-LEUKEMIA; LYMPHOPROLIFERATIVE DISORDERS; MYELOID-LEUKEMIA; FOLLOW-UP; DIAGNOSIS; CLADRIBINE; DYSFUNCTION; MUTATIONS; HISTOPATHOGENESIS; INSTABILITY;
D O I
10.1016/j.leukres.2015.09.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Telomeres, which protect the ends of chromosomes, are shortened in several hematologic malignancies, often with adverse prognostic implications, but their effect on prognosis of classic and variant hairy cell leukemia (HCL and HCLv) has not been reported. HCL/HCLv genomic DNA from 46 patients was studied by PCR to determine the ratio of telomere to single copy gene number (T/S). T/S was unrelated to diagnosis of HCL or HCLv (p = 0.27), but shorter T/S was associated with unmutated immunoglobulin rearrangements (p = 0.033) and age above the median at diagnosis (p = 0.017). Low T/S was associated with shorter overall survival from diagnosis (OS), particularly T/S <0.655 (p = 0.0064, adjusted p = 0.019). Shorter OS was also associated with presence of unmutated (p <0.0001) or IGHV4-34+ (p <0.0001) rearrangements, or increasing age (p = 0.0002). Multivariable analysis with Cox modeling showed that short T/S along with either unmutated or IGHV4-34+ rearrangements remained associated with reduced OS (p = 0.0071, p = 0.0024, respectively) after age adjustment. While T/S is relatively long in HCL and the disease usually indolent with excellent survival, shortened telomeres in HCL/HCLv are associated with decreased survival. Shortened T/S could represent a risk factor needing further investigation/intervention to determine if non-chemotherapy treatment options, in addition to or instead of chemotherapy, might be particularly useful. Published by Elsevier Ltd.
引用
收藏
页码:1360 / 1366
页数:7
相关论文
共 50 条
  • [21] Plasma cell leukemia morphologically resembling hairy cell leukemia variant
    Li, Ting
    Zhang, Yun
    Li, Kechao
    Yang, Li
    Wang, Yonghong
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (04) : 532 - 533
  • [22] No Loose Ends: A Review of the Pharmacotherapy of Hairy Cell and Hairy Cell Leukemia Variant
    King, Amber C.
    Kabel, Charlene C.
    Pappacena, Jeremy J.
    Stump, Sarah E.
    Daley, Ryan J.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (09) : 922 - 932
  • [23] Distinguishing hairy cell leukemia variant from hairy cell leukemia: Development and validation of diagnostic criteria
    Shao, Haipeng
    Calvo, Katherine R.
    Groenborg, Marlene
    Tembhare, Prashant R.
    Kreitman, Robert J.
    Stetler-Stevenson, Maryalice
    Yuan, Constance M.
    LEUKEMIA RESEARCH, 2013, 37 (04) : 401 - 409
  • [24] Alemtuzumab for the treatment of hairy cell leukemia and atypical hairy cell leukemia variant; report of two cases
    Telek, B.
    Batar, P.
    Rejto, L.
    Udvardy, M.
    BLOOD REVIEWS, 2007, 21 : S136 - S136
  • [25] PROGNOSTIC IMPACT OF TELOMERE LENGTH IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
    Aref, Salah
    Abou Zeid, Tarek
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 11 - 11
  • [26] HAIRY CELL LEUKEMIA - QUESTIONABLE B-CELL VARIANT
    COOPER, IA
    WESTE, S
    ADAMS, PB
    KRAFT, N
    IRONSIDE, PNJ
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1976, 6 (04): : 359 - 359
  • [27] Molecular Evidence of Ongoing Antigen Driven Somatic Hypermutation in the Natural History of Classic and Variant Hairy Cell Leukemia
    Arons, Evgeny
    Davies, Sarah
    Still, Katherine
    Chai, Nathan
    Potocka, Katherine
    Zhou, Hong
    Kreitman, Robert J.
    BLOOD, 2015, 126 (23)
  • [28] A UNIQUE VARIANT OF HAIRY-CELL LEUKEMIA IN JAPAN
    MACHII, T
    TOKUMINE, Y
    INOUE, R
    KITANI, T
    JAPANESE JOURNAL OF MEDICINE, 1990, 29 (04) : 379 - 383
  • [29] A PATIENT WITH A VARIANT FORM OF HAIRY-CELL LEUKEMIA
    KRAMER, PA
    OOSTERHUIS, WP
    VANKAMMEN, E
    HAZENBERG, BP
    BALHUIZEN, JC
    DINKELAAR, RB
    NETHERLANDS JOURNAL OF MEDICINE, 1993, 43 (5-6): : 262 - 268
  • [30] Hairy Cell Leukemia and Variant: Immunophenotypic Comparison and Variations
    Shao, H.
    Gronborg, M.
    Yuan, C. M.
    Kreitman, R. J.
    Stetler-Stevenson, M.
    MODERN PATHOLOGY, 2011, 24 : 320A - 321A